Failure to use the product strictly as directed may be illegal, dangerous and render the product ineffective
11.6 Evidence-Based Position Based on current literature: GLP-1 receptor agonists do not inherently cause universal nutrient depletion Intake-related vulnerability is plausible and patient-dependent Long-term micronutrient data remain limited Risk increases with magnitude and duration of weight loss Structured dietary strategy is protective Weight loss pharmacotherapy should be paired with nutritional planning
Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS, Stockwell BR
Convenient, hassle-free appointments
If you have a metabolic disorder, work with a healthcare provider who understands both your condition and peptide therapy
We typically consider these medications for people who Struggle with Obesity: Those who have a BMI of 30 or higher, or 27 or higher with other weight related health problems Have Difficulty Losing Weight Through Lifestyle Changes Alone: If youve tried losing weight with diet and exercise alone and were unsuccessful Patients with pain associated with their weight: Pain is a vicious cycle of non movement, weight gain, more pain, and so on
